Transgene Biotek Ltd.

TRABI

₹3.9

-0.26% (-0.01)

Market Cap

₹30 Cr.

P/E

0.00

About

Transgene Biotek Ltd (TBL) specializes in manufacturing drugs focusing on New Drug Delivery Systems such as Oral Delivery of Insulin, Hepatitis B Vaccine, and Pegylation for Sustained Release. They pr… Read more

Transgene Biotek Ltd (TBL) specializes in manufacturing drugs focusing on New Drug Delivery Sy… Read more

Low

52W Range

High

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

6 Yes

Positive for this company

2 Neutral

Neutral for this company

6 No

Negative for this company

3 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Revenue Recognition

Company is converting accounting profit to cash
Promoter Holding

Promoter has not sold any shares in the last 90 days
Other Income

Other income component is making ratios of the company look optically better

Price & Performance

Working Capital

Working capital of the company seems to be under control
ROE

Financial leverage has increased roe over 10 years
Share price

Share price has decreased over last 10 years more due to earnings
Debt

Company might have issues servicing its debt
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Balance Sheet Strength

Balance sheet is weak and might have solvency issues
Capex vs ROCE

Unable to calculate due to limited data
Current vs Historic Valuation

Unable to calculate due to limited data
Sales Growth

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Peer Comparison

FAQs on Transgene Biotek Ltd. Business

What does Transgene Biotek do?

Transgene Biotek Ltd specializes in manufacturing drugs including New Drug Delivery Systems, Biogenerics, Human Vaccines, and Cancer Drugs/Oncology. They also offer services in Diagnostics and CRO.

Who are the competitors of Transgene Biotek?

Transgene Biotek major competitors are KK Shah Hospitals, Nidan Labs. & Health, Family Care Hospital, Sharma Hospitals, Chennai Meena Multi, Soni Medicare, Global Longlife Hosp.
Market Cap of Transgene Biotek is ₹30 Crs.
While the median market cap of its peers are ₹26 Crs.

Is Transgene Biotek financially stable compared to its competitors?

Transgene Biotek seems to be less financially stable compared to its competitors.
Altman Z score of Transgene Biotek is -0.61 and is ranked 8 out of its 8 competitors.

View FAQ's On Shareprice

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Transgene Biotek Ltd.

Transgene Biotek Ltd.

About

Timeline

Company Timeline

6 Yes

2 Neutral

6 No

3 No Data

Accounting & Shareholding

Contingent Liabilities

Depreciation Effect

Pledge

Retail Holding

Revenue Recognition

Promoter Holding

Other Income

Price & Performance

Working Capital

ROE

Share price

Debt

Margin Stability

ROCE Strength

Balance Sheet Strength

Capex vs ROCE

Current vs Historic Valuation

Sales Growth

Product Wise Break-Up

UNLOCK PREMIUM

What does Transgene Biotek do?

Who are the competitors of Transgene Biotek?

Is Transgene Biotek financially stable compared to its competitors?

SIGN UP FOR FREE